Polypharmacy, the regular use of multiple medicines, has become increasingly common as populations age and more people live with several long-term health conditions. While it can be essential for effective disease management, it also carries significant risks that require careful oversight. Understanding when multiple medicines are appropriate and ensuring each one continues to deliver benefit without undue harm is central to safer healthcare.
What Polypharmacy Means and Why It Occurs
Polypharmacy is generally described as the regular use of five or more medicines. Taking ten or more is often called hyperpolypharmacy. The exact number is less important than whether the regimen is appropriate. Appropriate polypharmacy occurs when every medicine has a clear clinical indication, is supported by evidence, is effective for the individual, and the overall burden is manageable. Problematic or inappropriate polypharmacy arises when one or more medicines are unnecessary, duplicate therapy, interact harmfully, or create more risk than benefit.
This situation frequently develops in people with multimorbidity—multiple chronic conditions such as hypertension, diabetes, heart disease, arthritis, and mental health disorders. Disease-specific guidelines often recommend several medicines for each condition, leading to accumulation over time. Older adults are particularly affected because they are more likely to have several conditions and because age-related changes in kidney and liver function, body composition, and drug metabolism can alter how medicines work and increase sensitivity to side effects. Statistics show that a substantial proportion of older adults take five or more medicines regularly, with rates varying by country and setting but consistently high in outpatient and hospital populations.
The Risks of Unmonitored Multiple Medicines
The more medicines a person takes, the higher the chance of problems. Adverse drug events become more common, ranging from mild side effects to serious harm. Drug-drug interactions can amplify effects, reduce effectiveness, or produce unexpected toxicity. For example, combinations affecting blood pressure, electrolytes, or clotting can increase risks of falls, bleeding, or organ strain. Side effects such as dizziness, confusion, low blood pressure, or low sodium further raise the likelihood of falls and injuries, especially in older people.
Polypharmacy is also linked to reduced medication adherence. Complex regimens with multiple daily doses, different timings, and special instructions become hard to follow, leading to missed doses or errors. This can result in poorer disease control and additional prescriptions in a cycle sometimes called a prescribing cascade, where a new medicine is added to treat a side effect of an existing one. Studies associate higher numbers of medicines with greater risks of hospital admission, longer stays, functional decline, cognitive impairment, frailty, and even higher mortality. Healthcare systems also face increased costs from preventable admissions and treatments for medicine-related harm. The World Health Organization has identified medication safety in polypharmacy as a priority under its Medication Without Harm initiative, recognising the global scale of avoidable harm.
When Multiple Medicines Are Necessary and Beneficial
Not all polypharmacy is harmful. For many people living with several chronic conditions, a carefully chosen combination of medicines can control symptoms, prevent complications, reduce hospitalisations, and improve quality of life. Examples include regimens for heart failure, diabetes with cardiovascular risk, or post-transplant care, where multiple agents target different aspects of the disease. When medicines are selected based on the best available evidence, tailored to the individual, regularly reviewed, and aligned with the person’s goals and preferences, the benefits can outweigh the risks. Appropriate polypharmacy supports independence and better long-term outcomes when managed well.
The Critical Role of Regular Medication Reviews
Close monitoring through structured medication reviews is the key safeguard. A thorough review examines why each medicine was started, whether the original indication still exists, whether the current dose remains suitable, whether side effects or interactions are present, and whether simpler alternatives or non-medicine approaches could work. Reviews should consider the person’s overall health status, life expectancy, frailty, kidney and liver function, and personal priorities.
Deprescribing—the supervised process of reducing or stopping medicines that are no longer needed or whose risks now exceed benefits—forms an important part of this process. It is not about denying treatment but about optimising it. Deprescribing should be planned carefully, often involving gradual dose reduction, clear monitoring for withdrawal effects or return of symptoms, and shared decision-making with the patient and carers. Tools such as the Beers Criteria, STOPP/START criteria, and the Medication Appropriateness Index help clinicians identify potentially inappropriate medicines, though clinical judgement remains essential.
Multidisciplinary involvement strengthens reviews. Pharmacists often lead or support these processes, bringing expertise in interactions and practical regimen design. Doctors, nurses, and other team members contribute clinical context. Electronic systems can flag some interactions and duplicates, but they cannot replace thoughtful, person-centred assessment. Reviews are especially important at transitions of care—hospital discharge, changes in residence, or shifts in health status—when medication lists are most vulnerable to errors or outdated prescriptions.
Practical Steps for Safer Medicine Use
Patients and carers can play an active role by keeping an up-to-date list of all medicines, including over-the-counter products and supplements, and bringing it to every appointment. Reporting new symptoms promptly helps identify possible side effects or interactions early. Asking questions about the purpose, expected benefits, and possible downsides of each medicine supports informed decisions. Healthcare professionals should prioritise regular reviews for those on multiple medicines, those who are older or frail, those with recent hospital stays, and those whose conditions or goals have changed.
Balancing Necessity and Safety
Polypharmacy will remain a feature of modern healthcare because multimorbidity is common and effective treatments exist for many conditions. The challenge is not to eliminate multiple medicines but to ensure they remain the right ones for the individual at the right doses and for the right duration. Regular, structured medication reviews, combined with careful deprescribing when appropriate and ongoing monitoring, reduce harm while preserving benefit. This approach shifts the focus from simply counting pills to optimising therapy in a way that is safe, effective, and aligned with each person’s needs and circumstances. By treating polypharmacy as a dynamic situation requiring continuous attention rather than a fixed regimen, clinicians and patients can achieve better outcomes and greater confidence in everyday medicine use.
Read more – sevendollarmiracle.com
